Kazakhstan is strategically positioning itself as the undisputed medical tourism hub of Central Asia. The nation welcomed approximately 80,000 international patients last year, with an ambitious goal to escalate this figure to 300,000 annually. A key draw for these global healthcare seekers is Astana’s National Research Oncology Center, which houses the only proton therapy unit in the entire region. This forward-looking approach to healthcare delivery is clearly designed to attract a burgeoning number of international patients seeking advanced treatments.
Since 2020, Kazakhstan has witnessed an extraordinary surge in medical tourism, particularly from India and China, where patient numbers have increased by a staggering 40-fold and 24-fold respectively. Similarly, arrivals from Türkiye have tripled, underscoring a growing trust and preference for Kazakhstani healthcare services. According to data from the Ministry of Healthcare, patients are now traveling to Kazakhstan from approximately 50 different countries, highlighting its expanding global footprint as a healthcare destination. The Kazakhstan Medical Tourism Association anticipates that this upward trajectory could indeed see the number of foreign patients reach 300,000 per year, a growth trajectory that experts believe will be further propelled by the integration of advanced AI diagnostics and telemedicine solutions into cross-border healthcare offerings.
Pillars of Excellence: JCI Accreditation and Specialized Care
The burgeoning interest in Kazakhstan’s advanced medical cluster is significantly fueled by the relatively competitive treatment costs, as noted by Health Minister Akmaral Alnazarova. From an economic perspective, diagnostic procedures and various surgical interventions can be five to ten times more affordable than comparable services offered in the United States or Europe, presenting a compelling value proposition for patient travel. Minister Alnazarova affirmed the nation’s commitment to quality, stating, “All clinical protocols used in treatment are aligned with European standards. They also undergo health technology assessment, which has been implemented in Kazakhstan for more than ten years.” This adherence to rigorous international benchmarks is a critical assurance for those considering global healthcare options.
Furthermore, a remarkable nine clinics across the country have successfully secured accreditation from Joint Commission International (JCI). This accreditation is universally regarded as the gold standard for patient safety and the highest quality of care in the global healthcare industry, providing an essential layer of trust and reliability for international patient care. Several specialized institutions form the bedrock of Kazakhstan’s medical prowess:
- The National Centre for Neurosurgery: This facility is renowned for performing intricate operations on the brain and spinal cord. It uniquely operates the Gamma Knife system, a highly advanced tool for treating brain conditions, marking it as the sole installation of its kind within the region, as highlighted by the minister.
- The Cardiac Surgery Centre: A recognized regional leader in emergency cardiac care, this center performs heart transplants and other complex cardiovascular procedures that meet the demanding standards of leading international clinics, according to Minister Alnazarova.
- The National Center for Maternal and Child Health: This internationally accredited institution provides specialized care for young patients, focusing particularly on oncohematological diseases.
Among visitors from Europe, one of the most sought-after services is in vitro fertilization (IVF), a testament to Kazakhstan’s competitive pricing combined with high standards of care. Additionally, foreign patients are increasingly opting to travel to Kazakhstan for advanced high-tech dental procedures, further diversifying the nation’s appeal in the health tourism landscape.
Pioneering Proton Therapy: A Game Changer for Cross-Border Healthcare
Kazakhstan has made significant strides in expanding its specialized cancer treatment capabilities. In recent years, the country has seen the establishment of six new radiotherapy centers and 19 endoscopy units, alongside the modernization of 17 existing oncology centers. This robust infrastructure development underscores a clear commitment to enhancing the quality of care available to both domestic and international patients.
A monumental achievement occurred last year with the introduction of proton therapy, a cutting-edge and highly precise form of radiation treatment. This technology meticulously targets tumors while minimizing collateral damage to surrounding healthy tissues. With this advancement, Kazakhstan became the first country in Central Asia and only the 25th worldwide to deploy this sophisticated technology. The state-of-the-art facility, situated at the National Research Oncology Centre in Astana, possesses the capacity to treat up to 1,000 patients annually. It utilizes the advanced ProBeam 360 system, incorporating pioneering technologies developed in Sweden and the United States.
Gulnara Shakenova, a patient diagnosed with brain cancer, is among the inaugural individuals receiving treatment at this new proton therapy unit. Reflecting on her experience, she shared, “Every day I come here with hope and gratitude. The procedure is completely painless. You simply lie down and feel no discomfort.” This patient testimony highlights the humane and effective nature of the treatment, a crucial factor for those considering cross-border healthcare options.
Looking ahead, the National Research Oncology Centre aspires to evolve into a regional training and research hub for International Atomic Energy Agency (IAEA) programs in nuclear medicine. Indira Tleulessova, Head of the Centre for Radiation Technologies, confirmed this ambition, stating, “An IAEA mission visited in January to assess our infrastructure and professional capacity. We hope that in the coming years we will become an anchor centre supporting training for countries in the region.” This initiative would solidify Kazakhstan’s role as a knowledge center in global healthcare.
Fostering Innovation: Kazakhstan’s Vision for MedTech Leadership
Kazakhstan is articulating a clear and ambitious strategy to transform itself into a medical innovation hub within the next five years. Adlet Tabarov, deputy chair of the Salidat Kairbekova National Scientific Center for Healthcare Development, emphasized this forward-looking vision. The nation is actively strengthening its cooperation with neighboring states through strategic agreements focused on healthcare innovation and health technology assessment, promoting a collaborative regional approach to medical tourism.
Crucially, Kazakhstan is developing a comprehensive medical innovation cycle, which seamlessly integrates fundamental research, rigorous preclinical testing, essential clinical pilots, and localized production. The recent launch of a modern vivarium at the Nazarbayev University research cluster now facilitates full-scale preclinical studies to be conducted entirely within the country. MedTech expert Seitzhan Sypabek underscored the economic and strategic advantages of this development, noting, “This reduces costs and risks for investors and makes Kazakhstan more attractive as a regional R&D hub.” He further clarified that the current emphasis is on clinical pilots and early-stage implementation, rather than immediate large-scale rollout, indicating a measured and strategic approach to innovation.
An exemplary innovation is Cerebra AI, an advanced system engineered for the early detection of strokes. This platform is presently undergoing pilot implementation across 17 stroke centers in Kazakhstan, as well as several hospitals in Uzbekistan. Developers assert that this technology can detect strokes within minutes, a critical factor for significantly improving patient survival rates and outcomes. This project has already garnered international recognition and attracted foreign investment, including funding from the Singapore-based venture capital firm Quest Ventures, signaling global confidence in Kazakhstan’s MedTech potential.
Fueling Growth: The Venture Capital Landscape in Health Tourism
Kazakhstan has rapidly emerged as the preeminent destination for venture capital within the Central Asian region. In 2024, startups across the country successfully attracted €65 million in investment, accounting for a remarkable 74% of all venture capital deals executed in Central Asia, as reported by BGlobal Ventures, a part of Qazaqstan Investment Corporation. This robust investment climate is a powerful catalyst for the nation’s aspirations in health tourism.
Health technology stands out as one of the fastest-growing sectors, with funding models expanding well beyond traditional venture capital. A growing proportion of investment now originates from innovative hybrid models, which include corporate investments, joint research and development projects, and strategic technology-transfer partnerships, as observed by Seitzhan Sypabek. This diversified funding ecosystem is crucial for nurturing the next generation of solutions in international patient care and global healthcare.
Bottom Line
Kazakhstan is strategically leveraging its internationally accredited clinics, competitive pricing, and expanding portfolio of high-tech treatments, such as proton therapy, to firmly establish its healthcare sector as a leading regional destination for international patients. Its deliberate investments in advanced medical infrastructure and an innovation-friendly ecosystem signal a long-term commitment to becoming a significant player in the global medical tourism landscape.
- Strategic Investment in Advanced Care: The introduction of proton therapy and the continuous modernization of oncology centers demonstrate a clear commitment to offering cutting-edge treatments that attract international patients seeking high quality of care.
- Cost-Effectiveness Meets Global Standards: Significantly lower costs compared to Western counterparts, coupled with JCI accreditation and adherence to European clinical protocols, make Kazakhstan a highly attractive healthcare destination for cross-border healthcare.
- Innovation Ecosystem Development: The focus on a full medical innovation cycle, from research to local production, supported by a burgeoning venture capital scene, positions Kazakhstan not just as a treatment provider but also as a hub for MedTech R&D and global healthcare advancements.
- Regional Leadership and International Collaboration: Kazakhstan’s ambition to become a regional training hub for IAEA programs and its increasing cooperation with neighboring states underscore its role as a leader in cross-border healthcare and patient travel within Central Asia.
The news singal for this article was referred from: https://www.euronews.com/business/2026/03/18/how-this-country-is-emerging-as-a-medical-tourism-hub